Mutual Capital Partners

News

OrthoHelix Surgical puts $4.6M cherry on top of $14M fundraise

Total capital raised corrected 8:13 p.m., June 23, 2010. OrthoHelix Surgical Designs Inc. has added a $4.6 million cherry on top of its third fundraising round for a total of $14 million raised since early 2008. The company that recently relocated to Medina from Akron, Ohio, develops and makes implants and instruments that surgeons can […]

News

Q&A: Hemosphere CEO Doris Engibous

After more than 20 years in corporate America, Doris Engibous says she was “big-companied out.” So the medical technology veteran jumped at the opportunity to move from California to Minnesota six years ago to become a first-time CEO for Hemosphere Inc., which has developed a vein-access device for chronic kidney disease patients who need hemodialysis. […]

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.